-- 
AB Science, Ales, Bastide, Naturex : French Equity Preview

-- B y   A l a n   K a t z
-- 
2011-08-26T04:00:05Z

-- http://www.bloomberg.com/news/2011-08-25/ab-science-ales-bastide-naturex-french-equity-preview.html
The following companies’ shares may
be active in Paris. Symbols are in parentheses after company
names and prices are from the last close.  France ’s CAC 40 Index fell 20.55, or 0.7 percent, to 3,119.
The  SBF 120 Index (SBF120)  declined 0.5 percent.  AB Science SA (AB)  : The French drugmaker plans to sell
7.5 million euros ($10.8 million) of convertible bonds. The
bonds will pay interest of 1.25 percent and are convertible into
stock at a price of 12.65 euros a share. The shares gained 15
percent to 7.85 euros.  Ales Groupe (ALPHY)  : The maker of Laboratoires Lierac
cosmetics said second-quarter revenue rose to 52.4 million euros
from 43.5 million euros. The shares rose 1.4 percent to 12.43
euros.  Avenir Telecom (AVT)  SA: The distributor of mobile
telecommunications equipment said first-quarter revenue fell to
103.2 million euros from 129 million euros. The shares fell 1.4
percent to 71 euro cents.  Bastide le Confort Médical (BLC FP): The provider of home
health-care services said full-year revenue rose 9.2 percent to
109.1 million euros. The shares fell 0.4 percent to 7.70 euros.  Naturex (NRX)  : The producer of natural vegetable
ingredients and extracts said first-half net income rose to 9.7
million euros from 7.6 million euros. The stock rose 0.5 percent
to 53.58 euros.  To contact the reporter on this story:
 Alan Katz  in Paris at   akatz5@bloomberg.net .  To contact the editor responsible for this story:
Melissa Pozsgay at   mpozsgay@bloomberg.net . 